• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment.

作者信息

Roden Dan M, Harrington Robert A, Poppas Athena, Russo Andrea M

机构信息

Interim Division Chief, Division of Cardiovascular Medicine, Vanderbilt University School of Medicine.

President of the American Heart Association.

出版信息

Heart Rhythm. 2020 Jul;17(7):e231-e232. doi: 10.1016/j.hrthm.2020.04.016. Epub 2020 Apr 14.

DOI:10.1016/j.hrthm.2020.04.016
PMID:32302703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7194583/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/76a892f36d6d/fx4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/8e5f65f39874/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/3bde7d43005c/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/7f233acc9f34/fx3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/76a892f36d6d/fx4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/8e5f65f39874/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/3bde7d43005c/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/7f233acc9f34/fx3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/519a/7194583/76a892f36d6d/fx4_lrg.jpg

相似文献

1
Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment.探索性 COVID-19 治疗中药物相互作用对 QTc 间期的影响因素。
Heart Rhythm. 2020 Jul;17(7):e231-e232. doi: 10.1016/j.hrthm.2020.04.016. Epub 2020 Apr 14.
2
QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract Infection.羟氯喹/阿奇霉素联合治疗住院 SARS-CoV-2 下呼吸道感染患者时 QT 间期延长。
Clin Pharmacol Ther. 2020 Nov;108(5):1090-1097. doi: 10.1002/cpt.1968. Epub 2020 Jul 20.
3
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.接受羟氯喹和阿奇霉素治疗的新冠肺炎患者的QT间期。
Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-2.
4
Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.探索性 COVID-19 治疗中药物相互作用对 QTc 间期的影响因素
J Am Coll Cardiol. 2020 May 26;75(20):2623-2624. doi: 10.1016/j.jacc.2020.04.016. Epub 2020 Apr 10.
5
QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.在新冠肺炎患者使用羟氯喹和/或阿奇霉素期间控制QT间期以预防尖端扭转型室速
Arq Bras Cardiol. 2020 Jun;114(6):1061-1066. doi: 10.36660/abc.20200389. Epub 2020 Jul 3.
6
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.羟氯喹联合治疗 COVID-19 导致心脏传导异常的预测因素。
Int J Antimicrob Agents. 2020 Oct;56(4):106142. doi: 10.1016/j.ijantimicag.2020.106142. Epub 2020 Aug 24.
7
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.探索性新冠肺炎治疗中药物相互作用对QTc的影响因素
Circulation. 2020 Jun 16;141(24):e906-e907. doi: 10.1161/CIRCULATIONAHA.120.047521. Epub 2020 Apr 8.
8
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.羟氯喹和阿奇霉素治疗的 COVID-19 患者的心律失常谱和 24 小时 QT 间期变异性。
Int J Cardiol. 2020 Oct 1;316:280-284. doi: 10.1016/j.ijcard.2020.05.036. Epub 2020 May 19.
9
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).急件：针对新型冠状病毒病（COVID-19）可能的药物治疗的 QTc 延长和致扭转型心动过速的潜在风险的应对和规避指导建议。
Mayo Clin Proc. 2020 Jun;95(6):1213-1221. doi: 10.1016/j.mayocp.2020.03.024. Epub 2020 Apr 7.
10
Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.羟氯喹和阿奇霉素在 2019 冠状病毒病大流行中的应用经验：对 QT 间期监测的影响。
J Am Heart Assoc. 2020 Jun 16;9(12):e017144. doi: 10.1161/JAHA.120.017144. Epub 2020 May 28.

引用本文的文献

1
COVID-19 Vaccination and Cardiac Arrhythmias: A Review.COVID-19 疫苗接种与心律失常：综述。
Curr Cardiol Rep. 2023 Sep;25(9):925-940. doi: 10.1007/s11886-023-01921-7. Epub 2023 Aug 2.
2
Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment.使用真实世界数据、体外心肌细胞研究和死亡率评估评价瑞舒伐他汀致 QT 间期延长的风险。
Sci Rep. 2023 May 19;13(1):8108. doi: 10.1038/s41598-023-35146-z.
3
SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad.

本文引用的文献

1
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).急件：针对新型冠状病毒病（COVID-19）可能的药物治疗的 QTc 延长和致扭转型心动过速的潜在风险的应对和规避指导建议。
Mayo Clin Proc. 2020 Jun;95(6):1213-1221. doi: 10.1016/j.mayocp.2020.03.024. Epub 2020 Apr 7.
2
Toxicokinetics of hydroxychloroquine following a massive overdose.羟氯喹超大剂量摄入后的毒代动力学。
Am J Emerg Med. 2019 Dec;37(12):2264.e5-2264.e8. doi: 10.1016/j.ajem.2019.158387. Epub 2019 Aug 6.
3
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation.
SARS-CoV-2、心血管疾病和非编码 RNA：一个关联三联体。
Int J Mol Sci. 2021 Nov 12;22(22):12243. doi: 10.3390/ijms222212243.
4
Brief review: Cardiac complications and platelet activation in COVID-19 infection.简要综述：新型冠状病毒肺炎感染中的心脏并发症与血小板活化
Afr J Thorac Crit Care Med. 2020 Sep 16;26(3). doi: 10.7196/AJTCCM.2020.v26i3.107. eCollection 2020.
5
How COVID-19 Lockdown in Italy Has Affected Type of Calls and Management of Toxic Exposures: a Retrospective Analysis of a Poison Control Center Database From March 2020 to May 2020.意大利新冠疫情封锁措施如何影响中毒暴露的呼叫类型及管理：对2020年3月至2020年5月中毒控制中心数据库的回顾性分析
J Med Toxicol. 2021 Jul;17(3):250-256. doi: 10.1007/s13181-021-00839-2. Epub 2021 Apr 27.
6
Systemic manifestations of COVID-19.新型冠状病毒肺炎的全身表现
J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):435-442. doi: 10.4103/joacp.JOACP_359_20. Epub 2020 Oct 26.
7
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.新型冠状病毒肺炎门诊临床试验参与者中羟氯喹的安全性
Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500. doi: 10.1093/ofid/ofaa500. eCollection 2020 Nov.
8
Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review.人类冠状病毒感染相关心律失常的发生率及治疗：系统综述。
Eur J Clin Invest. 2021 Feb;51(2):e13428. doi: 10.1111/eci.13428. Epub 2020 Nov 26.
9
Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool.2019冠状病毒病中的心血管疾病：对10898例患者的系统评价和荟萃分析以及一种分诊风险分层工具的建议
Egypt Heart J. 2020 Jul 13;72(1):41. doi: 10.1186/s43044-020-00075-z.
10
Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.探索钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂对2019冠状病毒病的器官保护作用
J Clin Med. 2020 Jun 28;9(7):2030. doi: 10.3390/jcm9072030.
白细胞介素-6 抑制 hERG 是心脏和全身炎症中获得性长 QT 风险的基础。
PLoS One. 2018 Dec 6;13(12):e0208321. doi: 10.1371/journal.pone.0208321. eCollection 2018.
4
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice.阿奇霉素致 QT 间期延长的真实世界实践中的风险评估。
Biomed Res Int. 2018 Oct 14;2018:1574806. doi: 10.1155/2018/1574806. eCollection 2018.
5
Azithromycin Causes a Novel Proarrhythmic Syndrome.阿奇霉素会引发一种新型的心律失常综合征。
Circ Arrhythm Electrophysiol. 2017 Apr;10(4). doi: 10.1161/CIRCEP.115.003560.
6
Electrophysiologic Studies on the Risks and Potential Mechanism Underlying the Proarrhythmic Nature of Azithromycin.阿奇霉素致心律失常性质的风险和潜在机制的电生理研究。
Cardiovasc Toxicol. 2017 Oct;17(4):434-440. doi: 10.1007/s12012-017-9401-7.
7
Incidence of Sustained Ventricular Tachycardia in Patients with Prolonged QTc After the Administration of Azithromycin: A Retrospective Study.阿奇霉素给药后QTc延长患者持续性室性心动过速的发生率：一项回顾性研究
Drugs Real World Outcomes. 2016 Mar;3(1):99-105. doi: 10.1007/s40801-016-0062-9.
8
Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine.系统性红斑狼疮患者因羟氯喹导致危及生命的严重QTc间期延长
Case Rep Cardiol. 2016;2016:4626279. doi: 10.1155/2016/4626279. Epub 2016 Jul 12.
9
Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential.羟氯喹通过调节超极化激活电流If降低心率：新的电生理见解和治疗潜力。
Heart Rhythm. 2015 Oct;12(10):2186-94. doi: 10.1016/j.hrthm.2015.05.027. Epub 2015 May 27.
10
Assessment of temperature-induced hERG channel blockade variation by drugs.药物对温度诱导的人乙醚相关基因（hERG）通道阻滞变化的评估。
J Appl Toxicol. 2015 Jul;35(7):799-805. doi: 10.1002/jat.3074. Epub 2014 Oct 28.